PAREXEL International Profile

Performance

   

Odds of Distress

13%13%
Check how we calculate scores
Equity ratings for PAREXEL International Corp are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting June 26, 2019 and ending today August 25, 2019. Click here to learn more.

PAREXEL International Corp Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

PAREXEL International Key Fundamentals

PAREXEL International Against Markets

PAREXEL International Corporationration, a biopharmaceutical services company, offer clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology solutions and services for pharmaceutical, biotechnology, and medical device industries worldwide. more
NamePAREXEL International Corp
CEOEllen ZaneView All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock View All
RegionNorth America
Business Address195 West Street, Waltham, MA 02451, United States
ExchangeNASDAQ
CIK Number0000799729
ISINUS6994621075
BenchmarkDOW
Websitewww.parexel.com
Phone781 487 9900

PAREXEL International Corporate Directors

Dana Callow Presiding Independent Director
Patrick Fortune Independent Director
Eduard Holdener Independent Director
Additionally take a look at Your Equity Center. Please also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Search macroaxis.com